Mark Aitkenhead, PhD
Chief Commercial Officer
Dr. Aitkenhead worked in a variety of leadership positions at Thermo
Fisher Scientific since 2003, including most recently, General Manager
for Cellular Analysis Instrumentation and Global Commercial Leader for
the Clinical Next Generation Sequencing (NGS) Division. In the latter,
he was accountable for the sales strategy and execution of the entire
Ion Torrent NGS portfolio, a leading provider of clinical NGS
instrumentation, assays, and consumables in oncology, applied, and
research labs. During his tenure at Thermo Fisher, Dr. Aitkenhead also
worked in technical and application support, field sales, and global
customer care strategy. He received both his PhD in Anatomy and BMedSci
in Biomedical Sciences from The Queen’s University of Belfast in
Northern Ireland.